CJC-1295 with Ipamorelin – Research Use Only

This blend combines CJC-1295, a growth hormone–releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue (GHS). When studied together, these peptides offer complementary mechanisms of action that support research into growth hormone (GH) regulation and pituitary function.

• CJC-1295 (without DAC) is designed to mimic natural GHRH activity, stimulating the pituitary gland to release growth hormone.

• Ipamorelin acts as a ghrelin receptor agonist, selectively triggering GH release with minimal impact on cortisol or prolactin.

Researchers utilize this combination to study:

• Synergistic effects on growth hormone secretion

• Pituitary and hypothalamic signaling pathways

• Metabolic and cellular responses to dual peptide stimulation

Molecular Formula (CJC-1295): C₁₆₅H₂₇₁N₄₇O₄₆

Molecular Weight: 3647.1 g/mol

Molecular Formula (Ipamorelin): C₃₈H₄₉N₉O₅

Molecular Weight: 711.9 g/mol

This product is provided for laboratory research use only. It is not intended for human consumption, medical, or veterinary use.